@bgr.com 29 days ago
Incredible medicine that regrows teeth is about to enter human trials
@extremetech.com 1 year ago
Scientists Develop Cellular ‘Glue’ That Could Change Regenerative Medicine
@bgr.com 1 year ago
The 10 biggest Netflix movies in the world this week
@techcrunch.com 1 year ago
Post-pandemic, Telemedicine startups are evolving — this just one raised $6M for its hybrid approach
@bgr.com 1 year ago
Scientists tricked mosquitoes into delivering vaccines to humans
@extremetech.com 1 year ago
Drinking Coffee Reduces Risk of Kidney Injury, Study Finds
@bgr.com 1 year ago
This 10-second test could measure your risk of death, study says
@bgr.com 2 years ago
Recall warning: If you have this popular allergy medicine, stop using it now
@bgr.com 2 years ago
Research says watching TV every day might be slowly killing you
@nelsonSpinto 2 years ago
My surprised face reading this article: Great work by @kdpsinghlab et al. Lesson learned: #DataScience models in medicine are going nowhere without thorough evaluation and post-implementation monitoring. https://twitter.com/jamainternalmed/status/1407005406514319361
@bwpapiez 3 years ago
We are currently recruiting for Post doc in #MachineLearning for analysis of X-ray imaging, as part of Oxford-Novartis Collaboration for #ArtificialIntelligence in Medicine @bdi_oxford @NovartisUK https://www.jobs.ac.uk/job/CBA925/postdoctoral-researcher-in-machine-learning
@Getting_Smart 3 years ago
This recent post explores what we can learn from studying how #AI is used to create content in areas such as books, business and legal, medicine, song writing and visual arts. #EdLeaders #Teachers #Students #MachineLearning https://bit.ly/3gbmHwK
@MLuczak 4 years ago
12 PhD and post-doc position within the "Leibniz AI Lab" an international future laboratory to work on reliable and responsible AI in personalised medicine. Get in touch if you are interested in working with us. https://leibniz-ai-lab.de/?page_id=867 #phdchat #MachineLearning #ethics
@xconomy.com 4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks